Tamtam Try Tamtam free
Mehiläinen logo

Mehiläinen account plan

Healthcare services provider

At a glance

Mehiläinen is a Finnish private healthcare and social care group in seven countries with EUR 2,413.2 million of 2025 revenue and over 55,000 staff.

Mehiläinen Group, founded in Helsinki in 1909, is a private provider of healthcare and social care services in Finland, Estonia, Lithuania, Sweden, Germany, Romania and Serbia, trading as Meliva, Regina Maria and MediGroup outside Finland. It serves public sector, corporate and private customers with physician services, hospitals, diagnostics, occupational health, dental care and residential social care, and sells its BeeHealthy digital platform to external customers. In 2025 revenue grew 16.9% to EUR 2,413.2 million (pro forma EUR 3,068.2 million) and underlying EBITA reached EUR 339.4 million; it has 5.2 million customers, 1,450 units and over 55,000 employees and private practitioners. It is owned mainly by funds managed by CVC Capital Partners (41.0%) and Hellman & Friedman (38.1%). In May 2026 it agreed to acquire Aleris, adding Norway and Denmark.

Business units

Strategic priorities

Leading European outpatient provider by 2030
Mehiläinen aims to become a leading private provider of outpatient healthcare services in Europe by 2030, the most desired employer in its countries and a pioneer in healthcare digitalisation.
Acquisitive international growth
Around 200 acquisitions in 10 years; 2025 added InMedica, Regina Maria and MediGroup, and the Aleris deal of May 2026 would take the group to nine European countries and about 60,000 employees.
Digital healthcare and software
The OmaMehiläinen app has 2.2 million registered users in Finland, and BeeHealthy sells the platform in more than ten countries and to wellbeing services counties.
Regina Maria 3.0
Double the Romanian business by 2030 to above EUR 1 billion, enter new fields and expand into a new country.
Sustainability targets
SBTi-approved targets to cut Scope 1-2 emissions by 80% and Scope 3 intensity by 51.6% by 2030 against a 2023 base.

Investments and deals

Regina Maria and MediGroup
Romanian and Serbian providers consolidated from 18 December 2025 for consideration of EUR 774.2 million and EUR 100.1 million.
InMedica (Lithuania)
Lithuania's largest private healthcare company, acquired from 5 March 2025 and rebranded Meliva; it added EUR 146.2 million revenue in 2025. A new hospital opened in Vilnius and a clinic is under construction in Kaunas.
Aleris acquisition
Agreed 18 May 2026, subject to regulatory approval: about 100 clinics and hospitals in Denmark, Norway and Sweden with about 5,300 employees.
2025 investment total
Total investments of EUR 1,125.3 million, of which acquisitions EUR 1,018.5 million and tangible and intangible investments EUR 106.8 million.
Financing
EUR 350 million floating-rate and EUR 740 million 5.125% senior secured notes due 2032, plus the repricing of the EUR 1.86 billion term loan.

Challenges and risks

Public-sector cost cutting in Finland
Wellbeing services counties cut outsourcing and external staffing, and the Länsi-Pohja Hospital outsourcing ends in 2027.
High leverage
Interest-bearing net debt reached EUR 3,436.7 million with gearing of 366.7% and an equity ratio of 17.4%.
Staff availability
Availability of professionals is a named risk; employee benefit expenses of EUR 1,129.4 million are the largest cost.
Fixed-price contracts
Long-term contracts such as county outsourcing allow only limited price adjustment.
Internationalisation and currency
Expansion into new markets brings integration risk and larger foreign-currency exposure in Romania, Serbia and Sweden.

What leadership says

“We've done around 200 acquisitions over the past 10 years”

Janne-Olli Järvenpää, CEO · Nordea corporate-insights article, 2026-02-27

“We are the one of the most advanced healthcare providers in terms of digital processes”

Janne-Olli Järvenpää, CEO · Nordea corporate-insights article, 2026-02-27

“More than half of our patients, physician visits, diagnostic tests and surgical procedures are already outside Finland”

Janne-Olli Järvenpää, CEO · Nordea corporate-insights article, 2026-02-27

Where a supplier can help

Post-merger integration
Tied to the acquisitive growth priority: integrating Regina Maria, MediGroup, InMedica and Aleris calls for IT, process and procurement harmonisation at group scale.
Digital health and AI tools
Tied to the digital priority: patient app, AI and data tools that extend OmaMehiläinen and BeeHealthy across new countries.
Healthcare recruitment and workforce tools
Tied to the staff availability challenge: recruiting, scheduling and retention solutions for a workforce of over 55,000.
Cost efficiency for public contracts
Tied to Finnish public-sector cost cutting and fixed-price contracts: tools that lower cost per service help margins on county outsourcing.
Treasury and currency management
Tied to the leverage and currency challenges: treasury and FX services for a group with growing exposure outside the euro.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Mehiläinen?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Mehiläinen

What does Mehiläinen do?

Mehiläinen is a private provider of healthcare and social care services, running medical centres, hospitals, diagnostics, occupational health, dental care and residential care in seven countries.

What is Mehiläinen's revenue?

Revenue was EUR 2,413.2 million in 2025, up 16.9%; pro forma revenue including completed acquisitions was EUR 3,068.2 million.

How many employees does Mehiläinen have?

It has over 55,000 employees and private practitioners; the Aleris deal would bring the group to about 60,000 employees.

Who owns and leads Mehiläinen?

Funds managed by CVC Capital Partners (41.0%) and Hellman & Friedman (38.1%) are the main owners. Janne-Olli Järvenpää is CEO and Andreas Tallberg chairs the board.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)